Auxly Cannabis Group wholly-owned subsidiaries, Dosecann and Kolab Project have both been authorized by Health Canada to sell cannabis oil under the Cannabis Regulations. "The licences enable each of Dosecann and Kolab to commence initial sales of cannabis oil products to provincial and territorial purchasers; through Kolab’s flagship retail store in Saskatchewan; and to registered medical patients across the country through Kolab’s online portal," the team with the company explains.
Dosecann is Auxly’s state-of-the-art processing facility located in Prince Edward Island, which houses extraction, research and development, product formulation, in-house analytical testing and commercial manufacturing lines. "Dosecann’s team consists of leading experts that are dedicated to the development and manufacturing of innovative derivative cannabis products. Dosecann serves as Auxly’s manufacturing hub for all the Company’s branded derivative products."
"In anticipation of the receipt of its sales licence, Dosecann has been accumulating inventory of oil-based cannabis products in bottles, sprays and capsule formats. With the sales licence now in hand, Dosecann intends to commence delivery of such oil-based products in the coming weeks, beginning with several provinces in Atlantic Canada."
Dosecann has also submitted its attestations to Health Canada requesting an amendment to its oil sales licence to add the sale of cannabis extracts, edible cannabis, and cannabis topicals upon their legalization later this year. "Dosecann has successfully completed the development process for its derivative product portfolio, which will be expanded to include new classes of cannabis such as cannabis vaporizers, various edible formats and cannabis topicals later this year, upon receipt of necessary regulatory authorizations. Dosecann’s derivative products will be sold under Auxly’s suite of proprietary brands, including Dosecann and Kolab."
Kolab is Auxly’s craft cultivation facility located in Carleton Place, Ontario which is focused on providing high quality cannabis flower, pre-rolls and derivative products to its registered medical patients.
"The issuance of the oil sales licence permits Kolab to expand its current product offering from dried flower to include various Kolab branded oil-based products, to be manufactured by Dosecann. Kolab intends to provide its registered patients with access to such oil-based products in the coming weeks. Kolab branded oil-based products will also be available in Kolab’s flagship store in Saskatchewan in the near term," they explain.
"Kolab has also submitted its attestations to Health Canada requesting an amendment to its oil sales licence to add the sale of cannabis extracts, edible cannabis, and cannabis topicals upon their legalization later this year. Once legally permitted to sell derivative products, Kolab will further expand its product offering to include cannabis extracts including vapes and various edible cannabis products."
“We could not be more excited about receiving our oil sales license,” said Andrew Rock, Chief Operating Officer of Kolab. “Being able to expand on our product offering to now include oil-based products as well as our pre-rolls (always whole flower, never shake) and high quality flower will ensure our registered patients get the full spectrum of cannabis-based products, while maintaining the consistent modern formats they have come to expect from Kolab.”